Irmina Grygutis

Irmina Grygutis

Auto-generated profile, based on publicly available information

Irmina Grygutis

Nicolaus Copernicus Hospital in Gdańsk, Gdańsk, Poland

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
KŁKinga Łysak
Kinga Łysak
KFKornelia Julia Fimiarz
Kornelia Julia Fimiarz
IGIrmina Grygutis
Irmina Grygutis
SPSonia Pawełkiewicz
Sonia Pawełkiewicz
IPIga Pyż
Iga Pyż
IŁIga Łysak
Iga Łysak
Background: Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) is a chronic inflammatory disorder characterized by urothelial barrier disruption, pelvic pain, urinary urgency and frequency, and significant psychosocial burden. This condition represents a significant therapeutic challenge due to urothelial barrier dysfunction and the “washout effect,” which drastically shortens the exposure time of intravesically administered drugs. Objectives: This review aims to comprehensively analyze recent (2020–2026) advances in regenerative and nanotechnological approaches designed to overcome traditional limitations in IC/BPS treatment. Emphasis is placed on evaluating the clinical efficacy, biological mechanisms, and social impact of next-generation therapies. Methodology: A literature search was performed in PubMed, Scopus, MEDLINE, and Google Scholar for publications from 2020 to 2026 related to IC/BPS, focusing on thermosensitive hydrogels, nanocarriers, Platelet-Rich Plasma (PRP), amniotic-derived products, and gene-modulating therapies. Only peer‑reviewed preclinical and clinical research relevant to innovative IC/BPS management was analyzed. Results: Regenerative interventions, including Platelet-Rich Plasma (PRP) and Amniotic Bladder Therapy (ABT), demonstrate clinical symptom relief and improved Global Response Assessment (GRA) scores for up to 6 months. Network meta-analysis identifies PRP as highly effective for pain reduction ($SMD = -1.84$) compared to standard instillations. Advanced Drug Delivery Systems (DDS), such as thermosensitive hydrogels, extend intravesical drug residence to 5–7 days in preclinical models. Molecular precision therapies, specifically antisense Nerve Growth Factor (NGF) inhibitors and c-Jun N-terminal kinase (JNK) blockers, enable targeted intracellular modulation of neurogenic inflammation. Conclusion: The transition from palliative barrier substitution to biohybrid platforms integrating sustained drug delivery with regenerative signaling represents the current therapeutic paradigm. Future implementation requires standardized clinical protocols and large-scale randomized trials to address existing translational gaps.

24 June 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
IGIrmina Grygutis
Irmina Grygutis
OMOskar Mikołajczyk
Oskar Mikołajczyk
KFKornelia Julia Fimiarz
Kornelia Julia Fimiarz
UJUrszula JarzęCka
Urszula JarzęCka
KŁKinga Łysak
Kinga Łysak
MPMaja Podolak
Maja Podolak
Background: Treatment-resistant depression (TRD) is associated with substantial functional impairment, suicide risk, and health-care costs. Ketamine and its S-enantiomer, esketamine, have emerged as rapid-acting glutamatergic treatment options for TRD. Aim: This review aims to synthesize current evidence on the different ketamine administration routes for TRD, with a focus on acute and maintenance efficacy, dosing strategies, safety, infrastructure needs, and positioning within stepped-care algorithms. Methods: A narrative review of randomized controlled trials, meta-analyses, systematic reviews, and long-term open-label studies was performed. Outcomes were grouped by route and examined for (1) antidepressant response, (2) adverse-event profile, (3) required clinical resources, and (4) integration with other treatments such as electroconvulsive therapy and psychotherapy. Results: Ketamine and esketamine can be administered via intravenous (IV), intranasal (IN), oral, subcutaneous (SC), and intramuscular (IM) routes. IV racemic ketamine shows the strongest and fastest antidepressant effect but demands infusion-suite equipment and monitoring for transient hypertension and dissociation. FDA-approved IN esketamine offers robust long-term data but requires administration under supervised in-clinic administration and blood pressure monitoring. According to the reviewed studies, IV and IN routes remain the best-supported options for achieving a rapid response. Oral, sublingual and extended-release formulations provide easier access and lower cost, but have reduced bioavailability, modest effect sizes, and higher diversion risk. These routes of administration may be useful for maintenance treatment in resource-constrained settings. SC and IM injections achieve ~90 % bioavailability with minimal infrastructure, yet evidence is limited to small series. Conclusion: The optimal ketamine route is context-dependent, and requires balancing efficacy, safety, cost, and health-system capacity. Future research should include direct comparative trials and extended safety monitoring to better define the long-term efficacy, tolerability, and optimal clinical use of different ketamine administration routes.

30 June 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
KWKami Krzysztof Wójcik
Kami Krzysztof Wójcik
IGIrmina Grygutis
Irmina Grygutis
JKJulia KęPska
Julia KęPska
WOWeronika Olech
Weronika Olech
WKWiktor Kowalczyk
Wiktor Kowalczyk
MDMilena Dziedzina
Milena Dziedzina
Sarcopenia, traditionally associated with aging, has been increasingly recognized in younger populations. Early-onset muscle loss may have significant long-term metabolic and functional consequences. This review aims to summarize current evidence on the epidemiology, pathophysiology, risk factors, and preventive strategies of sarcopenia in young adults. A structured literature search was conducted using the PubMed database, prioritizing studies published between 2010 and 2025, including systematic reviews, meta-analyses, and narrative reviews. Current evidence suggests that the prevalence of sarcopenia in adult populations ranges from approximately 10% to over 20%, although data specific to younger individuals remain limited. In this group, sarcopenia is primarily associated with physical inactivity, inadequate nutrition, obesity, and metabolic dysfunction. Chronic low-grade inflammation and insulin resistance contribute to impaired muscle protein synthesis and increased catabolism, while early impairments in muscle function may remain clinically underrecognized. Resistance training and adequate protein intake remain the most effective preventive strategies, particularly when applied in combination. Early identification of at-risk individuals and targeted lifestyle interventions may play a crucial role in preventing long-term adverse health outcomes. Sarcopenia should therefore not be considered exclusively an age-related condition but rather a multifactorial process that may begin early in adulthood.

22 June 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
KFKornelia Julia Fimiarz
Kornelia Julia Fimiarz
KŁKinga Łysak
Kinga Łysak
SPSonia Pawełkiewicz
Sonia Pawełkiewicz
IGIrmina Grygutis
Irmina Grygutis
ASAleksandra Suchołbiak
Aleksandra Suchołbiak
MKMaja Kozielec
Maja Kozielec
Aim: This narrative review evaluates the current evidence on the impact of high-intensity focused ultrasound (HIFU), including MR-guided (MRgFUS) and ultrasound-guided (USgHIFU) techniques, on ovarian reserve in women treated for adenomyosis, with particular emphasis on anti-Müllerian hormone (AMH) level. Methods: narrative review included evidence from prospective and retrospective studies, randomized trials, and original research in patients with adenomyosis, identified through searches of PubMed/MEDLINE, Embase, Web of Science, and Google Scholar. Results: available studies consistently demonstrate that this treatment does not result in significant changes in AMH concentrations, irrespective of the method used, suggesting preservation of ovarian reserve. Conclusion: In contrast to more invasive treatment options, such as uterine artery embolization or hysterectomy, HIFU acts locally, minimizing the risk of damage to ovarian tissue and vascular supply. This enables the preservation of fertility, which is particularly important for women desiring future childbearing. However, the available evidence is limited by small sample sizes, heterogeneous study populations, and short follow-up periods. Further large-scale, prospective studies with long-term follow-up are needed to confirm the sustained safety of HIFU and its impact on reproductive outcomes.

30 June 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
ASAleksandra Serafin
Aleksandra Serafin
ASAleksandra Suchołbiak
Aleksandra Suchołbiak
KBKarolina Baran
Karolina Baran
MPMaja Podolak
Maja Podolak
KPKlaudia Pachulska
Klaudia Pachulska
ŁCŁukasz Chętko
Łukasz Chętko
Introduction: Epithelioid hemangioendothelioma (EHE) is a rare vascular tumor of low-to-intermediate malignant potential with an incompletely defined biological behaviour, exhibiting both benign and malignant features. It most commonly affects the liver, but may also involve other organs, such as the lungs and bones. Due to its heterogeneous clinical presentation and similarity to other vascular tumors primarily affecting the liver, misdiagnosis remains a common clinical challenge. Currently, several therapeutic approaches are used depending on various factors, but liver transplantation (LTx) is increasingly considered as the treatment option for patients with metastatic HEHE, particularly in unresectable cases. Several studies indicate a favorable prognosis following transplantation for HEHE. Aim of the Study: The aim of this study is to review the existing literature on treatment outcomes and to identify prognostic factors in patients undergoing LTx due to HEHE. Materials and Methods: A comprehensive literature review was performed using the PubMed database. Results and Conclusions: LTx is a crucial treatment option for patients with unresectable and multifocal HEHE. Current data indicate that post-transplant survival rates are favorable, with the potential to achieve durable, recurrence-free survival - even in the presence of extrahepatic metastases. Several prognostic factors have been identified that may influence post-transplant outcomes, including tumor burden, presence of extrahepatic disease (EHD), vascular invasion and tumor growth dynamics. In light of the limited efficacy of available systemic therapies, LTx should be considered the preferred treatment option in carefully selected patients with advanced HEHE. Nevertheless, long-term follow-up remains crucial to identify potential recurrence or complications.

29 June 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
MPMaja Podolak
Maja Podolak
ASAleksandra Serafin
Aleksandra Serafin
KBKarolina Baran
Karolina Baran
ASAleksandra Suchołbiak
Aleksandra Suchołbiak
IGIrmina Grygutis
Irmina Grygutis
MHMarta Maria Hajduk
Marta Maria Hajduk
Oxytocin (OXT), a hypothalamic nonapeptide stored in the posterior pituitary, has emerged as a multifaceted regulator extending far beyond its classical roles in parturition and lactation. In this narrative review, we summarize current knowledge regarding the role of the OXT system in patients with hypothalamic-pituitary dysfunction (HPD). We explore evidence of OXT’s clinical importance while highlighting specific symptoms of oxytocin deficiency (OXT-D), diagnostic limitations, and potential therapeutic strategies. A comprehensive literature search was performed in PubMed to identify relevant studies. Increasing evidence highlights OXT’s significant involvement in the modulation of neuropsychiatric processes, including social behavior, emotional regulation, stress responsiveness, and psychological well-being. In parallel, this hormone plays an important role in metabolic homeostasis, as well as solely peripheral physiological functions, including bone remodeling and obstetric and reproductive functions. Its dual central and peripheral actions underscore its integrative role in maintaining systemic homeostasis. While OXT-D is increasingly recognized following HPD, its assessment is limited by a lack of reliable diagnostic testing. Furthermore, although initial small-scale studies on OXT therapy show promise, the current body of evidence remains insufficient to fully support its transition into routine clinical practice. In this review, we highlight the need for further large, well-designed studies to confirm these preliminary findings and establish their clinical relevance.